Tuesday, 5 July 2022

Omicron sub-variants BA.4, BA.5 make up 70% of COVID variants in U.S. - CDC

Omicron sub-variants BA.4, BA.5 make up 70% of COVID variants in U.S. - CDC

The fast-spreading BA.4 and BA.5 sub-lineages of Omicron are estimated to make up a combined 70.1% of the coronavirus variants in the United States as of July 2, the U.S. Centers for Disease Control and Prevention said on Tuesday.

Florida's 15-week abortion ban takes effect after a brief injunction

Florida's ban on abortions past 15 weeks of pregnancy is now in effect after a court order blocking its enforcement on Tuesday was automatically put on hold.

British health minister Javid resigns, plunging government into chaos

British Health Secretary Sajid Javid resigned on Tuesday, plunging Prime Minister Boris Johnson's government into crisis.

U.S. drug distributors prevail in $2.5 billion West Virginia opioid case

Major U.S. drug distributors McKesson Corp , AmerisourceBergen Corp and Cardinal Health Inc are not responsible for fueling an opioid epidemic in a part of West Virginia, a federal judge ruled on Monday.

Panama reports country's first monkeypox case

Panama registered its first case of monkeypox in a resident who was infected after being in contact with tourists from Europe, Panama's health ministry said Tuesday.

Ireland expects to run 'extensive' autumn COVID vaccine campaign

Ireland expects to run an extensive vaccine drive against COVID-19 and flu ahead of a potentially worrying winter surge that could lead to the reimposition of mask wearing in certain settings, Deputy Prime Minister Leo Varadkar said on Tuesday.

Italy daily COVID cases exceed 100,000 for first time since February

Italy reported 132,274 COVID-19 cases on Tuesday, health ministry official figures showed, surpassing 100,000 for the first time since Feb. 8.

Wacker Chemie invests 100 million euros in mRNA factory

Chemicals group Wacker Chemie has commissioned construction firm Exyte to build a plant for mRNA components, a medical technology first widely used in COVID-19 vaccines, in an investment of 100 million euros ($102.97 million).

U.S. FDA to reconvene experts' meeting for Amylyx ALS drug

The U.S. Food and Drug Administration will reconvene a meeting of its outside experts to review Amylyx Pharmaceuticals' application for its amyotrophic lateral sclerosis (ALS) treatment, the company said on Tuesday.

CureVac files patent lawsuit in Germany against BioNTech over mRNA technology

CureVac has filed a patent lawsuit in Germany against BioNTech over its use of mRNA technology, marking one of the first known cases of a company going to court amid the fierce competition to develop a vaccine against the coronavirus.

Related Videos

Monkeypox could move into high-risk groups: WHO

Beijing tests millions over COVID cluster at bar

Shanghai to lock down millions again

at